Posted by JohnX2 on April 17, 2002, at 4:40:38
In reply to Re: New Antidepressants in Development?, posted by zero on April 15, 2002, at 13:31:16
note: flibanserin looked like an interesting medicine to me but was discontinued from clinical studies. The manufacturer did not state why.John
> (hope this long list is informative - zero)
> CenterWatch's comprehensive Directory of Drugs in Clinical Trials:
>
>
> Company Name Trade Name Generic Name Condition(s), Phase(s)
>
> GlaxoSmithKline Paxil, Seroxat paroxetine Depression, III
>
> Yamanouchi Pharmaceutical N/A YM-992 Depression, II
>
> Wyeth Research Effexor XR venlafaxine HCl Depression, FDA approved
>
> Janssen Pharmaceutica N/A YKP-10A Depression, IIa completed
>
> Merck N/A substance P antagonist candidates Depression, IIa
>
> Merck N/A MK-869 Depression, III
> Cephalon Provigil modafinil Depression, II
>
> Boehringer Ingelheim N/A flibanserin Depression, II
>
> Merck KgaA N/A anti-depressant Depression, II
> Sanofi-Synthelabo Pharmaceuticals N/A SR 58611 Depression, II b
>
> Eli Lilly N/A duloxetine HCl, LY-248686 Depression, NDA submitted
>
> Innapharma N/A INN-00835 Depression, II completed
>
> NeuroSearch A/S N/A NS-2389 Depression, II
>
> Eli Lilly Zyprexa olanzapine Depression, III
>
> Neurocrine Biosciences N/A NBI-34041 Depression, I
>
> NPS Pharmaceuticals N/A NPS 1506 Depression, Ib completed
>
> Kyowa Hakko N/A KW-6002 Depression, II
>
> Forest Laboratories N/A escitalopram Depression, NDA submitted
>
> AstraZeneca N/A robalzotan, NAD 299 Depression, II
>
> Solvay Pharmaceuticals N/A SLV 308 Depression, II
>
> Takeda Chemical Industries N/A TAK-637 Depression, II
>
> Organon Ariza 5HT-1A partial agonist Depression, III
>
> Annovis N/A amino-cyclopropane carboxylic acid Depression, I
>
> GlaxoSmithKline N/A GW 597599 Depression, I
>
> GlaxoSmithKline N/A SB 243213 Depression, Discontinued
>
> GlaxoSmithKline N/A SB 659746A, EMD 68843 Depression, II
>
> GlaxoSmithKline N/A GW 650250 Depression, II
>
> Janssen Pharmaceutica N/A R 107474 Depression, Discontinued
>
> Janssen Pharmaceutica N/A CRF receptor antagonist, NBI-37582 Depression, I
>
> Pfizer N/A NGD 98-1 Depression, II
>
> Eli Lilly Prozac Weekly fluoxetine HCI Depression, FDA approved
>
> Eli Lilly Prozac fluoxetine HCl Depression, FDA approved
>
> Eli Lilly N/A Olanzapine-fluoxetine combination Depression, III
>
> Fabre-Kramer Pharmaceuticals N/A gepirone Depression, III completed
>
> Pfizer N/A JO-1784, CI-1019 Depression, Discontinued
>
> Dainippon Pharmaceutical N/A moclobemide Depression, II
>
> Pfizer N/A CP-122,721 Depression, II
>
> Hoffmann-La Roche N/A NK-1 Depression, I
>
> Otsuka America Pharmaceutical N/A OPC-14523 Depression, II
>
> Organon N/A ORG-12962 Depression, II
>
> Cortex Pharmaceuticals N/A ORG-24448, CX-619 Depression, I
>
> Organon N/A ORG-34167 Depression, I
>
> Organon N/A ORG-34517 Depression, II
>
> Pharmacia Vestra reboxetine Depression, FDA denied
>
> Mitsubishi Chemical Corporation N/A MCI-225 Depression, II
>
> Somerset Pharmaceuticals Emsam selegiline Depression, NDA denied
>
> GlaxoSmithKline N/A SB723620 Depression, I
>
> Sepracor N/A (R)-sibutramine metabolite Depression, II
poster:JohnX2
thread:103083
URL: http://www.dr-bob.org/babble/20020416/msgs/103320.html